Eli Lilly & Co. (LLY), Incyte (INCY) Announce Significant Data from Two Baricitinib Phase 3s in RA
Go back to Eli Lilly & Co. (LLY), Incyte (INCY) Announce Significant Data from Two Baricitinib Phase 3s in RA| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 51.40 -0.25 (0.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $51.65 | 52 Week High | $118.49 | |||
| Open | $51.65 | 52 Week Low | $55.00 | |||
| Day High | $51.78 | P/E | N/A | |||
| Day Low | $51.27 | EPS | $-0.56 | |||
| Volume | 92,837 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 736.24 -9.45 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $745.69 | 52 Week High | $88.16 | |||
| Open | $752.64 | 52 Week Low | $67.88 | |||
| Day High | $752.64 | P/E | 170.43 | |||
| Day Low | $735.92 | EPS | $4.32 | |||
| Volume | 427,226 | |||||
